Search results
Blueprint Medicines Co. to Post Q1 2025 Earnings of ($0.93) Per Share, Wedbush Forecasts...
ETF DAILY NEWS· 4 days agoBlueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Analysts... issued their Q1 2025 earnings estimates for Blueprint Medicines in ...
Michael Landsittel Sells 10,000 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) Stock
ETF DAILY NEWS· 3 days agoBlueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) CFO Michael Landsittel sold 10,000 shares of the business’s stock in a transaction ...
Blueprint Medicines Co. (NASDAQ:BPMC) Expected to Post Q2 2024 Earnings of ($1.10) Per Share
ETF DAILY NEWS· 2 days agoBlueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Stock analysts at Leerink Partnrs issued their Q2 2024 earnings per share (EPS) ...
Pat Beyer Buys 3,000 Shares of CONMED Co. (NYSE:CNMD) Stock
ETF DAILY NEWS· 7 days agoCONMED Co. (NYSE:CNMD – Get Free Report) COO Pat Beyer acquired 3,000 shares of the stock in a transaction dated Tuesday, April 30th. The stock ...
Revolution Medicines, Inc. (NASDAQ:RVMD) CFO Jack Anders Sells 10,000 Shares of Stock
ETF DAILY NEWS· 6 days agoRevolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) CFO Jack Anders sold 10,000 shares of the business’s stock in a transaction that occurred on ...
GSK (LON:GSK) Reaches New 1-Year High at $1,767.50
ETF DAILY NEWS· 12 hours agoGSK plc (LON:GSK – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Wednesday . The company traded as high as GBX 1,767.50 ...
ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Cut to $22.00 by Analysts at Bank of America
ETF DAILY NEWS· 8 hours agoThe brokerage currently has a “neutral” rating on the biopharmaceutical company’s stock. Bank of America‘s price objective would indicate a potential upside ...
Metagenomi (NASDAQ:MGX) Research Coverage Started at HC Wainwright
ETF DAILY NEWS· 3 days agoStock analysts at HC Wainwright initiated coverage on shares of Metagenomi (NASDAQ:MGX – Get Free Report) in a research report issued to clients and investors on Tuesday, ...
JPMorgan Chase & Co. Increases GSK (LON:GSK) Price Target to GBX 1,660
ETF DAILY NEWS· 7 days agoGSK (LON:GSK – Get Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from GBX 1,530 ($19.22) to GBX 1,660 ($20.85 ...
Exelixis (NASDAQ:EXEL) Earns “Outperform” Rating from William Blair
ETF DAILY NEWS· 7 days agoWilliam Blair reaffirmed their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a report published on Wednesday, RTT News reports. Barclays lowered Exelixis from an overweight ...